MedPath

To study the efficacy of Agnimantha Beej Choorna (Agnimantha powder) with Takra Anupana in Mutrashmari Pidam (Pain management in urolithiasis)

Not yet recruiting
Conditions
Calculus of kidney with calculus of ureter. Ayurveda Condition: Mutrashmari, (2) ICD-10 Condition: O||Medical and Surgical. Ayurveda Condition: Mutrashmari Pidam ,
Registration Number
CTRI/2022/05/042728
Lead Sponsor
Hon Annasaheb Dange Ayurvedic Medical College and post graduation research center Ashta
Brief Summary

This study will evaluate the efficacy of Agnimanth Beej Choorna in Mutrashmari Pidam.

During this trial trying to evaluate the untoward effect of Agnimanth Beej Choorna in Mutrashmari as their is no previous work done on Agnimanth beej Choorna so emphasis will be made to find out easy cost effective method to control Mutrashmari Pidam with no side effects.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
62
Inclusion Criteria

Patient aged between 15 to 60 years will be selected irrespective of sex,prakruti,occupation,race,chronicity,socioeconomic status.

Exclusion Criteria

1)K/C/O Malignancy of urinary tract 2)STD,HIV Infection 3)Uncontrolled DM 4)Pyelonephritis.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Agnimantha Beeja Churna with Takra is effective in Mutrashmari Pidam ( Pain management). Pain will be assessed by VAS scale.1 week. | Primary out come will be 1 week for both groups.
Secondary Outcome Measures
NameTimeMethod
Mefenamic acid is effective in Mutrashmari Pidam ( Pain management). Pain will be assessed by VAS scale.2 week

Trial Locations

Locations (1)

Dhanvantari Ayurved hospital Astha, tal Walwa Dist Sangli pin code 416301

🇮🇳

Sangli, MAHARASHTRA, India

Dhanvantari Ayurved hospital Astha, tal Walwa Dist Sangli pin code 416301
🇮🇳Sangli, MAHARASHTRA, India
Dr Manoj patil
Principal investigator
9422613195
dr.patilmanoj77@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.